| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2021―Apr―18 |
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies |
Milo Gatti, Fabrizio De Ponti, Federico Pea |
| 2 |
[GO] |
2021―Mrz―20 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies |
Anthony T. Reder, Diego Centonze, Maria L. Naylor, Anjali Nagpal, Rajani Rajbhandari, Arman Altincatal, et al. (+8) Michelle Kim, Aaron Berdofe, Maha Radhakrishnan, Eunice Jung, Alfred W. Sandrock, Karen Smirnakis, Catrinel Popescu, Carl de Moor |
| 3 |
[GO] |
2020―Aug―11 |
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination |
Crystal Zheng, Indrani Kar, Claire Kaori Chen, Crystal Sau, Sophia Woodson, Alessandro Serra, Hesham Abboud |
|
